IBIO iBio, Inc.

iBio Inc is a biotechnology company. It is engaged in commercializing its proprietary platform technologies, iBioLaunch for vaccines and therapeutic proteins & iBioModulator for vaccine enhancement and developing select product candidates.

$1.46  -0.02 (-1.35%)
As of 06/22/2021 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/04/2011
Outstanding shares:  217,850,344
Average volume:  4,771,677
Market cap:   $333,311,026
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    451033203
ISIN:        US4510332038
Sedol:      BG43QY2

---

Valuation   (See tab for details)

---

PE ratio:   -11.89
PB ratio:   3.05
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%